Founded in 2018, Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Our mission is to transform the integration of genomics into healthcare and pharmaceutical research with our sophisticated data analysis platform. Serving a wide range of clients, genetics labs, and life-science companies, Geneyx offers unmatched precision in genetic analysis and research.
We are continuously enhancing the Geneyx platform with AI/ML tools and capabilities to streamline processes, substantially reduce turnaround times, increase accuracy, and ensure limitless scalability. Our strategic direction is towards adopting a Multiomics approach, integrating DNA and RNA analysis and Epigenetics our automated pipeline will transform raw data into personalized reports, advancing precision medicine and genomic research.
Workflow automation is valuable in high-throughput environments but is also important for obtaining accurate results by removing manual errors. Geneyx Analysis promotes automation using APIs and batch upload features, which enable secure communication with LIMS and other electronic systems for large sample workflows. Geneyx Analysis can also be implemented at any stage within existing bioinformatic pipelines, and provides detailed audit trails to monitor every step of the workflow.
One distinct database valuable to whole genome sequencing analysis is the Geneyx Clinical Knowledgebase. This knowledgebase integrates machine learning to provide novel biomedical insights for gene-phenotype associations in coding and non-coding regions of the genome. Coupled with our innovative phenotype-driven interpretation algorithm, these features resulted in the identification of variants that exome sequencing failed to identify. As whole genome sequencing becomes increasingly important within the clinical space, Geneyx Analysis will be a leading solution for scientists and clinical researchers in support of accurate and automated variant interpretation.
Staying relevant on annotation sources is fundamental to accurate variant interpretation. To alleviate the complexities with updating annotations, Geneyx Analysis implements automated annotation and database updates. In addition to well-known annotations, literature sources and best-practice guidelines are also updated regularly.
Following analysis and interpretation of NGS data are reporting most labs outsource reporting to third-party platforms. This however can be expensive, tedious, and time-consuming. Geneyx Analysis includes reporting capabilities within the software and allows reports to be fully customizable, including rendering in different languages.
With 200 accounts across 52 countries and thousands of users, Geneyx to date has analyzed over 600,000 samples. Due to our unique “ phenotyper” ® users report a more than 65% detection yield (compared to 33% industry average). Geneyx also contributes significantly to various National Genome Projects. Our platform excels in secondary and tertiary analysis of exome sequencing, whole genome sequencing, and gene panels, utilizing both short and long-read sequencing technologies for germline and somatic cases.
We are proud to have created valuable partnerships with distinguished organizations such as Oxford Nanopore Technologies (ONT) and Pacific Bioscience (PacBio), as well as renowned tech giants like Microsoft, AWS, and Accenture. Since last July we have been the sole system deployed on the G42 cloud in the Emirates. These alliances enable us to leverage the latest advancements in technology and drive discoveries in genomic analysis.
Geneyx was selected for leading research institutes like, Stanford University, Children’s Mercy Research Institute (Kansas City) Bambino-Gesu, (Rome) Hadassah Medical center, Son Espases (Spain), Queen Marry (Hong Kong), LifeCell India, Juno Labs and Arcensus.
Geneyx is more than a platform; it’s a community driving towards a future where genomics informs every aspect of healthcare. Whether you’re a clinical scientist, researcher, or technologist, we invite you to be part of this transformative journey with Geneyx – where innovation meets genomic healthcare.
In summary, Geneyx Analysis is a leading solution for NGS interpretation and evaluation. Our platform aims to allow users worldwide to harness genetic data within their current infrastructure. Geneyx Analysis addresses all bioinformatic needs and has been shown to improve detection yields and analysis turnaround time, specifically in high-throughput settings.
We’re always here for any questions, issues or brilliant ideas. Fill out the form below and a member of our team will be in touch.
Contact us to set a live demo
Whether you have general questions about our solutions or would like to schedule a demo or to suggest collaboration – our team is on hand for you.
